Search research articles
Contact Us
Filters
Showing results (151-160 of 223) with videos related to
Page
of 23
Sort By:
Neuro-Oncology Advances
|
January 15, 2024
Comparison of volumetric and 2D-based response methods in the PNOC-001 pediatric low-grade glioma clinical trial
Marc von Reppert, Divya Ramakrishnan, Sarah C Brüningk, et al.
The Journal of Experimental Medicine
|
December 6, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
Zinal S Chheda, Gary Kohanbash, Kaori Okada, et al.
The Lancet. Oncology
|
October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the art
Benjamin H Kann, Arastoo Vossough, Sarah C Brüningk, et al.
Neuro-Oncology
|
January 23, 2025
Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the PBTA and PNOC
Ryan J Corbett, Cricket C Gullickson, Zhuangzhuang Geng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2023
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial
Daphne A Haas-Kogan, Mariam S Aboian, Jane E Minturn, et al.
Journal of Neuro-Oncology
|
April 17, 2026
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors
Mohammad H Abu-Arja, Zeynab Rajabi, Mary Claire McGlynn, et al.
The Lancet. Oncology
|
October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation
Anahita Fathi Kazerooni, Ariana M Familiar, Mariam Aboian, et al.
Neuro-Oncology
|
August 30, 2024
Multimodal deep learning improves recurrence risk prediction in pediatric low-grade gliomas
Maryamalsadat Mahootiha, Divyanshu Tak, Zezhong Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003
Cassie Kline, Payal Jain, Lindsay Kilburn, et al.
The Journal of Clinical Investigation
|
June 15, 2022
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma
Sabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 223) with videos related to
Sort By:
Page
of 23
Neuro-Oncology Advances
|
January 15, 2024
Comparison of volumetric and 2D-based response methods in the PNOC-001 pediatric low-grade glioma clinical trial
Marc von Reppert, Divya Ramakrishnan, Sarah C Brüningk, et al.
The Journal of Experimental Medicine
|
December 6, 2017
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
Zinal S Chheda, Gary Kohanbash, Kaori Okada, et al.
The Lancet. Oncology
|
October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the art
Benjamin H Kann, Arastoo Vossough, Sarah C Brüningk, et al.
Neuro-Oncology
|
January 23, 2025
Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the PBTA and PNOC
Ryan J Corbett, Cricket C Gullickson, Zhuangzhuang Geng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2023
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial
Daphne A Haas-Kogan, Mariam S Aboian, Jane E Minturn, et al.
Journal of Neuro-Oncology
|
April 17, 2026
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors
Mohammad H Abu-Arja, Zeynab Rajabi, Mary Claire McGlynn, et al.
The Lancet. Oncology
|
October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translation
Anahita Fathi Kazerooni, Ariana M Familiar, Mariam Aboian, et al.
Neuro-Oncology
|
August 30, 2024
Multimodal deep learning improves recurrence risk prediction in pediatric low-grade gliomas
Maryamalsadat Mahootiha, Divyanshu Tak, Zezhong Ye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2022
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003
Cassie Kline, Payal Jain, Lindsay Kilburn, et al.
The Journal of Clinical Investigation
|
June 15, 2022
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma
Sabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.
Page
of 23